The many roles of BAF (mSWI/SNF) and PBAF complexes in cancer

C Hodges, JG Kirkland… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
During the last decade, a host of epigenetic mechanisms were found to contribute to cancer
and other human diseases. Several genomic studies have revealed that∼ 20% of …

Lung cancer epigenetics: from knowledge to applications

M Duruisseaux, M Esteller - Seminars in cancer biology, 2018 - Elsevier
Lung cancer is the leading cause of cancer-related mortality worldwide. Advances in our
understanding of the genomics of lung cancer have led to substantial progress in the …

SWI/SNF nucleosome remodellers and cancer

BG Wilson, CWM Roberts - Nature Reviews Cancer, 2011 - nature.com
SWI/SNF chromatin remodelling complexes use the energy of ATP hydrolysis to remodel
nucleosomes and to modulate transcription. Growing evidence indicates that these …

The spectrum of SWI/SNF mutations, ubiquitous in human cancers

AH Shain, JR Pollack - PloS one, 2013 - journals.plos.org
SWI/SNF is a multi-subunit chromatin remodeling complex that uses the energy of ATP
hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating …

Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer

Y Lissanu Deribe, Y Sun, C Terranova, F Khan… - Nature medicine, 2018 - nature.com
Lung cancer is a devastating disease that remains a top cause of cancer mortality. Despite
improvements with targeted and immunotherapies, the majority of patients with lung cancer …

[HTML][HTML] SMARCA4: Current status and future perspectives in non-small-cell lung cancer

Y Tian, L Xu, X Li, H Li, M Zhao - Cancer Letters, 2023 - Elsevier
SMARCA4, also known as transcription activator, is an ATP-dependent catalytic subunit of
SWI/SNF (SWItch/Sucrose NonFermentable) chromatin-remodeling complexes that …

The SWI/SNF complex and cancer

D Reisman, S Glaros, EA Thompson - Oncogene, 2009 - nature.com
The mammalian SWI/SNF complexes mediate ATP-dependent chromatin remodeling
processes that are critical for differentiation and proliferation. Not surprisingly, loss of …

A synthetic lethality–based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1

T Oike, H Ogiwara, Y Tominaga, K Ito, O Ando, K Tsuta… - Cancer research, 2013 - AACR
The occurrence of inactivating mutations in SWI/SNF chromatin-remodeling genes in
common cancers has attracted a great deal of interest. However, mechanistic strategies to …

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

R Schneppenheim, MC Frühwald, S Gesk… - The American Journal of …, 2010 - cell.com
Rhabdoid tumors of early infancy are highly aggressive with consequent poor prognosis.
Most cases show inactivation of the SMARCB1 (also known as INI1 and hSNF5) tumor …

Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity

L Yang, W Tu, L Huang, B Miao… - Journal of Medicinal …, 2023 - ACS Publications
SMARCA2 is an attractive synthetic lethality target for human cancers with SMARCA4
deficiency. Herein, we report the design, synthesis, and biological evaluation of selective …